1Braun DB. Current status of suture-mediated closure: what is the cost of comfort? [J]. Vase Intervent Radiol, 2003,14 (6) : 677-681.
2Abando A, Hood D, Weaver F,et al. The use of the Angioseal deviee for femoral artery elosure[J]. J Vasc Surg, 2004,40 (2) :287-90.
3Van Den Broek T, Liqui Lung PF, Suttorp MJ,et al. Vascular occlusion as a late complication of the Anglo-Seal closure device[J]. Minerva Cardioangiol, 2007,55(6):815.
4Wille J, Vos JA, Overtoom TT,et al. Acute leg ischemia: the dark side of a pereutaneous femoral artery closure deviee[J]. Ann Vasc Surg, 2006 ,20(2) :278-81.
5Jaff MR, Hadley G, Hermiller JB,et al. The safety and efficacy of the StarCloseVascular Closure System: the ultrasound substudy of the CLIP study[J]. Catheter Cardiovasc Interv, 2006 ,68(5):684.
6Veasey RA, Large JK, Silberbauer J, et al. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital-the SCOAST study[J]. Int J Clin Pract, 2008 ,62(6) :912.
7Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures[J]. A meta analysis, 2004,44(6) : 1200- 1209.
8Jensen J, Saleh N, Jensen U, et al. The Inflammatory Response to Femoral Arterial Closure Devices: A Randomized Comparison Among FemoStop, AngioSeal, and Perclose[J]. Cardiovasc Intervent Radiol, 2008,31(4) : 751.
9Gargiulo NJ, Veith FJ, Ohki T, et al. Histologic and duplex comparison of the perelose and angio-seal pereutaneous elosure deviees[J]. Vascular, 2007 ,15(1) :24.
